Popular terms

[SEARCH]

Efavirenz topics
Human Immunodeficiency Virus
Reverse Transcriptase
Lamivudine
Reverse Transcriptase Inhibitor
Chloroform
Atazanavir
Protease Inhibitor
Wet Milling
Reverse Transcriptase Inhibitors
Nevirapine
Hiv Reverse Transcriptase
Delavirdine

Follow us on Twitter
twitter icon@FreshPatents

Web & Computing
Cloud Computing
Ecommerce
Search patents
Smartphone patents
Social Media patents
Video patents
Website patents
Web Server
Android patents
Copyright patents
Database patents
Programming patents
Wearable Computing
Webcam patents

Web Companies
Apple patents
Google patents
Adobe patents
Ebay patents
Oracle patents
Yahoo patents

[SEARCH]

Efavirenz patents



      
           
This page is updated frequently with new Efavirenz-related patent applications. Subscribe to the Efavirenz RSS feed to automatically get the update: related Efavirenz RSS feeds. RSS updates for this page: Efavirenz RSS RSS



Date/App# patent app List of recent Efavirenz-related patents
06/25/15
20150174147 
 Unitary pharmaceutical dosage form patent thumbnailUnitary pharmaceutical dosage form
In accordance with this invention a novel pharmaceutical product containing efavirenz, emtricitabine and tenofovir df are provided as a multicomponent unitary oral dosage form, component 1 comprising tenofovir df (and, optionally, emtricitabine) and component 2 comprising efavirenz, wherein components 1 and 2 are in a stabilizing configuration. In preferred embodiments component 1 is made by dry granulation..
Bristol-myers Squibb & Gilead Sciences, Llc


05/21/15
20150141376 
 Pharmaceutical compositions of anti-viral compounds and process for preparation thereof patent thumbnailPharmaceutical compositions of anti-viral compounds and process for preparation thereof
Pharmaceutical compositions of anti-viral compounds, process for preparation and method of using the same are provided. Particularly, the present invention relates to chemically stable pharmaceutical compositions of efavirenz, emtricitabine and tenofovir disoproxil fumarate with optionally one or more pharmaceutically acceptable excipients, process for preparation and method for the treatment or prevention of the symptoms or effects of an hiv infection in an infected patient..

01/15/15
20150018297 
 Composition for preventing or treating degenerative brain diseases including compound downregulating expression of bace1 proteins patent thumbnailComposition for preventing or treating degenerative brain diseases including compound downregulating expression of bace1 proteins
The present disclosure relates to a pharmaceutical composition, a health functional food composition, and a method for preventing or treating a brain disease or diabetes. The pharmaceutical composition, health functional food composition, and method includes at least one active ingredient that is chlorhexidine, thioguanosine, mebendazole, fenbendazole, colchicine, farnesol, trimethobenzamide hydrochloride, disulfuram, azathioprine, mebeverine hydrochloride, zaprinast, tosufloxacin hydrochloride, efavirenz, thiostrepton, probenecid, entacapone, harmine hydrochloride, flunisolide, thimerosal, hexestrol, sulfaquinoxaline sodium salt, monensin sodium salt, raloxifene hydrochloride, 2-chloropyrazine, or topotecan..
Research & Business Foundation Sungkyunkwan University


12/18/14
20140370102 
 Method and composition for pharmaceutical product patent thumbnailMethod and composition for pharmaceutical product
This invention is directed to a composition comprising dry granulated tenofovir df and emtricitabine, and a method for making same. Dry granulation was unexpectedly found to be important in preparing a tenofovir df containing composition suitable for inclusion in a combination dosage form containing emtricitabine, efavirenz and tenofovir df..
Gilead Sciences, Inc.


12/11/14
20140364389 
 Combination therapy patent thumbnailCombination therapy
The present invention relates to a combination therapy for treating an hiv infection or inhibiting integrase comprising (s)-6-(3-chloro-2-fluorobenzyl)-1-(1-hydroxymethyl-2-methylpropyl)-7-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid (“compound a”) or a pharmaceutically acceptable solvate or salt thereof in combination with at least one other anti-hiv agent. In some embodiments of the present invention, the other anti-hiv agents are chosen from reverse transcriptase inhibitors and protease inhibitors.

08/07/14
20140220140 
 Compositions of efavirenz patent thumbnailCompositions of efavirenz
The present inventions relates to a solid composition and an aqueous dispersion comprising nanoparticles of the anti-retroviral drug efavirenz. The solid composition and aqueous dispersion additionally comprise a mixture of a hydrophilic polymer and a surfactant.

05/29/14
20140148449 
Highly loaded amorphous efavirenz composition and process for preparing the same
A stable and high loading ternary solid dispersion composition comprising (a) about 50% wt. To about 90% wt.

02/06/14
20140037732 
 Method and composition for pharmaceutical product patent thumbnailMethod and composition for pharmaceutical product
This invention is directed to a composition comprising dry granulated tenofovir df and emtricitabine, and a method for making same. Dry granulation was unexpectedly found to be important in preparing a tenofovir df containing composition suitable for inclusion in a combination dosage form containing emtricitabine, efavirenz and tenofovir df..

02/06/14
20140037724 
 Unitary pharmaceutical dosage form patent thumbnailUnitary pharmaceutical dosage form
In accordance with this invention a novel pharmaceutical product containing efavirenz, emtricitabine and tenofovir df are provided as a multicomponent unitary oral dosage form, component 1 comprising tenofovir df (and, optionally, emtricitabine) and component 2 comprising efavirenz, wherein components 1 and 2 are in a stabilizing configuration. In preferred embodiments component 1 is made by dry granulation..

11/14/13
20130302415 
 Pharmaceutical composition patent thumbnailPharmaceutical composition
A pharmaceutical composition comprising efavirenz wherein the efavirenz is in the form of nanoparticles is disclosed.. .

06/27/13
20130165650 

Process for the preparation of efavirenz


As a free base or a salt thereof, with diphosgene (tcmcf, trichloromethylchloroformate) cl3co—cocl in an organic solvent or in a biphasic medium comprised of an organic solvent and water, preferably but not mandatorily in the presence of a weak base in an amount sufficient to neutralize the reaction mixture or in an up to 30% molar excess of such amount.. .



Popular terms: [SEARCH]

Efavirenz topics: Human Immunodeficiency Virus, Reverse Transcriptase, Lamivudine, Reverse Transcriptase Inhibitor, Chloroform, Atazanavir, Protease Inhibitor, Wet Milling, Reverse Transcriptase Inhibitors, Nevirapine, Hiv Reverse Transcriptase, Delavirdine

Follow us on Twitter
twitter icon@FreshPatents

###

This listing is a sample listing of patent applications related to Efavirenz for is only meant as a recent sample of applications filed, not a comprehensive history. There may be associated servicemarks and trademarks related to these patents. Please check with patent attorney if you need further assistance or plan to use for business purposes. This patent data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Efavirenz with additional patents listed. Browse our RSS directory or Search for other possible listings.


2.5907

987

3 - 0 - 22